GEVO vs OEC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GEVO exhibits critical fundamental weakness, highlighted by a Piotroski F-Score of 1/9, indicating severe financial instability. While the company shows explosive year-over-year revenue growth of 695.60% and recent earnings beats, these are overshadowed by negative profit margins and a complete lack of positive cash flow. The disconnect between bullish analyst targets ($5.50) and aggressive insider selling (15 sell transactions, 0 buys) suggests a high-risk speculative profile. The technical trend is currently bearish, and the lack of a Graham Number reflects the company's inability to generate earnings.
OEC exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a negative ROE of -16.31%. While the stock appears cheap on a Price-to-Sales (0.23) and Price-to-Book (1.10) basis, these are value trap indicators given the crashing YoY EPS growth of -197.1% and negative profit margins. High leverage (Debt/Equity of 2.89) combined with a poor Quick Ratio (0.49) suggests significant liquidity risk. The current price of $7.52 trades at a premium to the analyst target price of $6.31, indicating further downside potential.
Compare Another Pair
Related Comparisons
GEVO vs OEC: Head-to-Head Comparison
This page compares Gevo, Inc. (GEVO) and Orion S.A. (OEC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.